Cargando…

Reduced Segmentation of Lesions Is Comparable to Whole-Body Segmentation for Response Assessment by PSMA PET/CT: Initial Experience with the Keyhole Approach

SIMPLE SUMMARY: The calculation of PSMA-positive tumor volume (PSMA-TV) of the whole body from PSMA PET scans for response evaluation remains a time-consuming procedure. We hypothesized that it may be possible to quantify changes in PSMA-TV by considering only a limited number of representative tumo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hartrampf, Philipp E., Krebs, Markus, Peter, Lea, Heinrich, Marieke, Ruffing, Julia, Kalogirou, Charis, Weinke, Maximilian, Brumberg, Joachim, Kübler, Hubert, Buck, Andreas K., Werner, Rudolf A., Seitz, Anna Katharina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137844/ https://www.ncbi.nlm.nih.gov/pubmed/35625388 http://dx.doi.org/10.3390/biology11050660

Ejemplares similares

Metabolic Tumour Volume from PSMA PET/CT Scans of Prostate Cancer Patients during Chemotherapy—Do Different Software Solutions Deliver Comparable Results?
por: Hartrampf, Philipp E., et al.
Publicado: (2020)

Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET/CT
por: Mihatsch, Patrick W., et al.
Publicado: (2022)

Detection Rate of (68)Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy
por: Brumberg, Joachim, et al.
Publicado: (2020)

SUV(mean) on baseline [(18)F]PSMA-1007 PET and clinical parameters are associated with survival in prostate cancer patients scheduled for [(177)Lu]Lu-PSMA I&T
por: Hartrampf, Philipp E., et al.
Publicado: (2023)

Prognostic implications of dual tracer PET/CT: PSMA ligand and [(18)F]FDG PET/CT in patients undergoing [(177)Lu]PSMA radioligand therapy
por: Michalski, Kerstin, et al.
Publicado: (2020)

Matched-pair analysis of [(177)Lu]Lu-PSMA I&T and [(177)Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
por: Hartrampf, Philipp E., et al.
Publicado: (2022)

Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [(177)Lu]Lu-PSMA I&T
por: Hartrampf, Philipp E., et al.
Publicado: (2022)

Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [(177)Lu]Lu-PSMA I&T during long-term follow-up
por: Hartrampf, Philipp E., et al.
Publicado: (2022)

Pitfalls in PSMA-PET/CT: intensive bone marrow uptake in a case with polycythemia vera
por: Hartrampf, Philipp E., et al.
Publicado: (2020)

High Interobserver Agreement on PSMA PET/CT Even in the Absence of Clinical Data
por: Bundschuh, Ralph A., et al.
Publicado: (2023)

Development of Discordant Hypermetabolic Prostate Cancer Lesions in the Course of [(177)Lu]PSMA Radioligand Therapy and Their Possible Influence on Patient Outcome
por: Hartrampf, Philipp E., et al.
Publicado: (2021)

External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on (68)Ga-PSMA PET images
por: Ghezzo, Samuele, et al.
Publicado: (2023)

mCRPC patients with PSA fluctuations under radioligand therapy have comparable survival benefits relative to patients with sustained PSA decrease
por: Hartrampf, Philipp E., et al.
Publicado: (2022)

Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET
por: Leung, Kevin H., et al.
Publicado: (2022)

Angiogenesis as Therapeutic Target in Metastatic Prostate Cancer – Narrowing the Gap Between Bench and Bedside
por: Solimando, Antonio Giovanni, et al.
Publicado: (2022)

Critical Evaluation of a microRNA-Based Risk Classifier Predicting Cancer-Specific Survival in Renal Cell Carcinoma with Tumor Thrombus of the Inferior Vena Cava
por: Kotlyar, Mischa J., et al.
Publicado: (2023)

Electrocorticographic representations of segmental features in continuous speech
por: Lotte, Fabien, et al.
Publicado: (2015)

Predicting Microenvironment in CXCR4- and FAP-Positive Solid Tumors—A Pan-Cancer Machine Learning Workflow for Theranostic Target Structures
por: Marquardt, André, et al.
Publicado: (2023)

Reliability of gradient-based segmentation for measuring metabolic parameters influenced by uptake time on 18F-PSMA-1007 PET/CT for prostate cancer
por: Lau, Yu Ching, et al.
Publicado: (2022)

Identification of miR-21-5p and miR-210-3p serum levels as biomarkers for patients with papillary renal cell carcinoma: a multicenter analysis
por: Kalogirou, Charis, et al.
Publicado: (2020)

Keyhole Flap Nipple Reconstruction
por: Chen, Joseph I., et al.
Publicado: (2016)

Application of Keyhole Microneurosurgery in China
por: Chen, Li-Gang, et al.
Publicado: (2017)

Subgroup-Independent Mapping of Renal Cell Carcinoma—Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic Boundaries
por: Marquardt, André, et al.
Publicado: (2021)

miR-221 Augments TRAIL-Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1
por: Krebs, Markus, et al.
Publicado: (2019)

PSMA PET in Imaging Prostate Cancer
por: Tsechelidis, Ioannis, et al.
Publicado: (2022)

All that Glitters on PSMA is Not a Lesion: An Unusual Artifact on PSMA PET/CT
por: Dev, Indraja D., et al.
Publicado: (2021)

miR-221-3p Regulates VEGFR2 Expression in High-Risk Prostate Cancer and Represents an Escape Mechanism from Sunitinib In Vitro
por: Krebs, Markus, et al.
Publicado: (2020)

Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [(68)Ga]Ga-PSMA-11 PET/CT images
por: Kendrick, Jake, et al.
Publicado: (2022)

Keyhole approach in the neuroendoscopic treatment for hydrocephalus
por: Cai, Qiang, et al.
Publicado: (2017)

Keyhole Approach and Neuroendoscopy for Cerebral Aneurysms
por: Cho, Won-Sang, et al.
Publicado: (2017)

Endoscopic Keyhole Approach for Intracranial Epidermoid
por: Verma, Pawan K., et al.
Publicado: (2021)

PSMA Expression in Multinodular Thyroid Neoplasm on Simultaneous Ga-68-PSMA PET/MRI
por: Jena, Amarnath, et al.
Publicado: (2017)

E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
por: Ceci, Francesco, et al.
Publicado: (2021)

Immunization of mice with the self-peptide ACBP coupled to keyhole limpet hemocyanin
por: Montégut, Léa, et al.
Publicado: (2022)

Machine Learning CT-Based Automatic Nodal Segmentation and PET Semi-Quantification of Intraoperative (68)Ga-PSMA-11 PET/CT Images in High-Risk Prostate Cancer: A Pilot Study
por: Rovera, Guido, et al.
Publicado: (2023)

Expanding the role of PSMA PET in active surveillance
por: Jain, Anika, et al.
Publicado: (2023)

PSMA-PET in the early stages of prostate cancer
por: Barbosa, Felipe de Galiza
Publicado: (2023)

Prognostic utility of RECIP 1.0 with manual and AI-based segmentations in biochemically recurrent prostate cancer from [(68)Ga]Ga-PSMA-11 PET images
por: Kendrick, Jake, et al.
Publicado: (2023)

FDG-PET Versus PSMA-PET: A Patient With Prostate Cancer
por: Kichloo, Asim, et al.
Publicado: (2020)

Can PSMA PET/CT help in dose-tailoring in post-prostatectomy radiotherapy?
por: Champion, Ambroise, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ua3qhoucpq1k4pbo0j74elqttu